Intelligent Bio Solutions Inc. (INBS) Stock

Intelligent Bio Solutions Inc., a dynamic life sciences company based in New York, New York, specializes in the development of non-invasive, real-time monitoring and diagnostic solutions for patients and their healthcare providers. Formerly known as GBS Inc., the company rebranded to Intelligent Bio Solutions Inc. in October 2022, reflecting its commitment to advancing innovative bio-sensing technologies. Intelligent Bio Solutions is dedicated to enhancing healthcare through its cutting-edge biosensor platforms.

One of the company's flagship products is the Saliva Glucose Biosensor, which utilizes organic thin-film transistor technology to measure glucose levels in saliva, offering a non-invasive approach to diabetes management. Additionally, Intelligent Bio Solutions is actively developing the SARS-CoV-2 Biosensor, designed to complement RNA virus detection tests, thereby enhancing diagnostic capabilities in infectious disease management.

Beyond its current offerings, Intelligent Bio Solutions is expanding its biosensor platform to encompass a wide range of diagnostic modalities. This includes biochemistry, immunology, tumor markers, hormones, and nucleic acid tests, underscoring its commitment to addressing diverse healthcare needs. As a subsidiary of Life Science Biosensor Diagnostics Pty Ltd, Intelligent Bio Solutions leverages strategic partnerships and scientific expertise to drive innovation in bio-sensing technologies, aiming to revolutionize patient care and diagnostic accuracy worldwide.